VRDN

$21.24-4.71%website ↗

Viridian Therapeutics, Inc.\DE

Market Cap

$2.6B

Sector

Materials

Industry

Biotechnology

Beta

1.08

5yr monthly vs SPY

Price Chart

Loading…

Signals

Insider Velocity

Market & Alt Data

News

10

recent articles

Analyst Consensus

Strong Buy

23 analysts

Velocity Score

23.98x

Sell Rate (90d)

157.91/mo

Sell Baseline

0.00/mo

Unique Sellers (90d)

1

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-08-19	2026-08-20	Tousignant Jennifer	Chief Legal Officer	Sale	14.2K	$24.50	$348K	0	View
2026-05-11	2026-05-13	Fairmount Funds Management LLC	Director	Purchase	1.18M	$17.00	$20.00M	5.09M	View
2025-10-23	2025-10-27	Fairmount Funds Management LLC	Director	Purchase	454.5K	$22.00	$10.00M	3.91M	View

Recent News

Alpha Buying: 4 Biotech Stocks a Healthcare Specialist Is Buying

Benzinga · 2026-09-03

Viridian Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference

Yahoo · 2026-09-02

Viridian Therapeutics to See 'Minimal' Revenue Growth in H2, RBC Capital Markets Says

Yahoo Finance · 2026-08-07

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Yahoo Finance · 2026-08-06

Informational purposes only, not investment advice.